Evidence map›Paper›PMID 21681420›Full record

ArticleMolecular biology reports2012

Transgenic mice with overexpression of mutated human optineurin(E50K) in the retina.

Qingfeng Meng, Zheng Xiao, Huiping Yuan, Fei Xue, Yuanmao Zhu, Xinrong Zhou, Binbin Yang, Jingbo Sun, Bo Meng, Xian Sun and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Glaucoma Animal Models beyond Chronic IOP Increase.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Qingfeng MengDepartment of Ophthalmology, Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu street, Nangang district, Heilongjiang, Harbin 150086, China.
Zheng Xiao
Huiping Yuan
Fei Xue
Yuanmao Zhu
Xinrong Zhou
Binbin Yang
Jingbo Sun
Bo Meng
Xian Sun
Fang Cheng
Second Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNHarbin Veterinary Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present work, Site-directed mutagenesis to insert the Glu50Lys amino acid substitution was achieved by PCR using plasmid pBluescript-OPTN. Mutated human OPTN(E50K) gene-driven mouse c-kit promoter was constructed and confirmed by endonuclease digestion and sequence analysis. Transgenic mice were generated via the microinjection method. PCR and DNA dot blot were used to screen the positive transgenic mice. RT-PCR analyzed the RNA level and location of mutated human OPTN(E50K) mRNA expression in transgenic mice. Western blot and immunohistochemistry were used to detect the level and location of mutated human OPTN(E50K) expression in transgenic mice. A transgenic mouse model with overexpression of mutated human OPTN(E50K) in retina was successfully established. The transgene was integrated and transmitted into the chromosome of transgenic mice. Mutated human OPTN(E50K) gene was controlled by c-kit promoter and expressed in the retina in mice. Mutated human OPTN(E50K) in transgenic mice was higher than that of wild type C57BL/6J mice. Our studies had provided a new transgenic model for investigating the molecular properties of mutated human OPTN(E50K).

Indexed as

Models, AnimalAmino Acid SubstitutionAnimalsCell Cycle ProteinsGenetic Predisposition to DiseaseGlaucomaHumansImmunoblottingMembrane Transport ProteinsMiceMice, Inbred C57BLMice, TransgenicMicroinjectionsPromoter Regions, GeneticProto-Oncogene Proteins c-kitRetinaCell Cycle ProteinsMembrane Transport ProteinsOPTN protein, humanProto-Oncogene Proteins c-kitTranscription Factor TFIIIA

Identifiers

PMID21681420
OpenAlexW1992245252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.